Oral Modified Release Dosage Forms Flashcards

1
Q

Compressed tablets are tablets that undergo ___ compression cycle

A

one

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Enteric coated tablets have a coating designed to disintegrate in the _____
but not in the _____.

A

intestine

stomach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Effervescent tablets are uncoated compressed granular effervescent
salts that release ___ when in contact with ____

A

gas

water

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

define Modified Release (MR) dosage forms

A

any solid dosage forms that have been designed to release a drug in a pre-determined manner.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

A modified release dosage from is dosage form where the rate of drug release:

a. tailored in a specific manner
b. not particularly controlled
c. tailored for a specific disease
d. driven by disintegration

A

a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

A reason for formulating a drug as a delayed-release tablet is:

a. improves organoleptic properties
b. protects the small intestine
c. protects the drug from the stomach
d. less expensive than the IR tablet

A

c

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

T/F Once the enteric coat is removed, a delayed-release tablet will have the same dissolution profile as an immediate-release tablet with the same formulation without the delayed-release coat.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

A repetab is this type of tablet formulation:

a. Single compressed tablet
b. Multiple compressed tablet
c. Effervescent tablet
d. Enteric-coated tablet

A

b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

The extended-release formulation is intended to mimic a steady-state drug absorption profile through:

a. Zero-order release
b. First-order release
c. Pusedo-first-order release
d. Second- order release

A

a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

T/F Typically extended-release formulations must disintegrate to exhibit their pharmacologic effects.

A

false

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Characteristics of insoluble matrix systems include, they:

a. dissolve slowly to allow for drug diffusion
b. form aqueous channels to allow for drug diffusion
c. have a rate controlling membrane that allows for drug diffusion
d. push the drug out of the tablet through osmosis

A

b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Drugs formulated in ER dosage forms should have half-lives __________.

a. > 8 hr
b. between 2-8 hr
c. < 2 hr

A

b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

T/F LA drugs are ideal for ER dosage forms.

A

false

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what OTC drug should you avoid when taking DR drugs?

A

antacids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

T/F An enteric coated tablet can be cut/crushed without dose dumping effects.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

T/F A repetab can be cut without toxic effects.

17
Q

T/F Buccal & SL spaces have high keratinization leading to increased permeability.

18
Q

T/F buccals and sl tablets bypass 1st pass effect

19
Q

T/F buccals and sl tablets can be used for local or systemic effects

20
Q

The transport of monosaccharides and amino acids in the buccal and SL space occurs through:

a. Passive transcellular diffusion
b. Passive paracellular diffusion
c. Carrier-mediated transcellular diffusion
d. Transcellular endocytic processes

21
Q

T/F Buccal & SL routes of administration are intended for local action

22
Q

Which oral transmucosal route of administration allows for prolonged contact for drug delivery?

a. Buccal
b. SL
c. Hard Palate
d. Gingivae

23
Q

What is the major advantage of using the transmucosal space for drug delivery?

a. Large absorptive surface area
b. High patient compliance
c. Bypasses first-pass metabolism
d. Intended for local action

24
Q

T/F SL tablets are coated for rapid drug release.

25
Q

Identify the critical excipient in SL tablets responsible for the quick onset of action through this route.

a. Super disintegrants
b. Sweeteners
c. Flavorants
d. Buffers
e. glidants
f. diluents

26
Q

The primary barrier to SL drug delivery is _________ production , requiring drug to be absorbed quickly.

A

high salivary

27
Q

T/F Buccal tablets need to disintegrate quickly to be bioavailable

28
Q

Identify the critical excipient in buccal tablets responsible for the prolonged action through this route.

a. Super disintegrants
b. Sweeteners
c. Flavorants
d. mucoadhesives
e. glidants
f. diluents

29
Q

Which of the buccal dosage forms will allow for the sustained release of the drug? [Select all that apply]

a. Lozenges
b. Tablets
c. Patches